| (19) |
 |
|
(11) |
EP 1 775 343 A8 |
| (12) |
CORRECTED EUROPEAN PATENT APPLICATION |
|
published in accordance with Art. 158(3) EPC |
| (15) |
Correction information: |
|
Corrected version no 1 (W1 A1) |
| (48) |
Corrigendum issued on: |
|
26.09.2007 Bulletin 2007/39 |
| (43) |
Date of publication: |
|
18.04.2007 Bulletin 2007/16 |
| (22) |
Date of filing: 28.04.2005 |
|
| (51) |
International Patent Classification (IPC):
|
| (86) |
International application number: |
|
PCT/JP2005/008175 |
| (87) |
International publication number: |
|
WO 2006/001122 (05.01.2006 Gazette 2006/01) |
|
| (84) |
Designated Contracting States: |
|
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI
SK TR |
| (30) |
Priority: |
24.06.2004 JP 2004187028
29.10.2004 WO PCT/JP2004/016089
|
| (71) |
Applicant: DNAVEC Research, Inc. |
|
Tsukuba-shi,
Ibaraki 305-0856 (JP) |
|
| (72) |
Inventors: |
|
- Okano, Shinji
Fukuoka-shi, Fukuoka 8120041 (JP)
- Yonemitsu, Yoshikazu
Fukuoka-shi, Fukuoka 8130043 (JP)
- Sueishi, Katsuo
Fukuoka-shi, Fukuoka 8150073 (JP)
- Shibata, Satoko
Fukuoka-shi, Fukuoka 8120061 (JP)
- Hasegawa, Mamoru
Tsukuba-shi, Ibaraki 3050856 (JP)
- Kondo, Haruhiko
Fukuoka-shi, Fukuoka 8150031 (JP)
|
| (74) |
Representative: Vossius & Partner |
|
Siebertstrasse 4
81675 München
81675 München (DE) |
|
| |
|
| (54) |
ANTICANCER AGENT CONTAINING DENDRITIC CELL HAVING RNA VIRUS TRANSFERRED THEREINTO |
(57) The present invention provides anticancer agents comprising dendritic cells introduced
with RNA viruses. The present invention also provides methods for producing anticancer
agents, which comprise the step of preparing dendritic cells introduced with RNA viruses.
The present invention also provides methods for treating cancers using dendritic cells
introduced with RNA viruses. The present invention provides effective methods for
treating cancers, which use RNA viruses and dendritic cells in combination.